Sandoz Group AG

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Public

Established: 1986-01-01

Employees: 20K

Market Cap: $19B

Website: http://www.sandoz.com

Clinical Trials

A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Phase 3

Completed

Conditions: Rhinitis, Allergic, Seasonal

Interventions: Drug: Mometasone furoate 50 mcg/actuation nasal spray (Lek Pharmaceuticals)
Drug: Mometasone furoate (Nasonex®) 50 mcg/actuation nasal spray
Drug: Placebo

First Posted Date: 2009-12-24

Last Posted Date: 2021-02-03

Lead Sponsor: Sandoz

Target Recruit Count: 795

Registration Number: NCT01038427

Locations: 🇺🇸
Sylvana Research, San Antonio, Texas, United States

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: Rebetol 200 Capsules (Schering Corporation, U.S.A.)
Drug: Ribavirin 200 Capsules (Geneva Pharmaceutical, U.S.A.)

First Posted Date: 2009-08-17

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 24

Registration Number: NCT00959933

Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: High Blood Pressure
Migraine Headaches
Chest Pain

Interventions: Drug: Nadolol (1 x 80 mg) Tablets (Invamed, Inc)
Drug: Corgard (1 x 80 mg) Tablets (Bristol Laboratories)

First Posted Date: 2009-08-17

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 34

Registration Number: NCT00960245

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Phase 1

Completed

Conditions: Hirsutism
Prostate Cancer

Interventions: Drug: Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA)
Drug: Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA)

First Posted Date: 2009-08-17

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00960310

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions

Phase 1

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: Ribavirin 200 mg Oral Capsule (Geneva Pharmaceutical, U.S.A.)
Drug: Rebetol 200 mg Oral Capsule (Schering Corporation, U.S.A.)

First Posted Date: 2009-08-17

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 38

Registration Number: NCT00960479

Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)

Phase 1

Completed

Conditions: Rheumatoid Arthritis
Osteoarthritis

Interventions: Drug: Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)
Drug: Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)

First Posted Date: 2009-08-14

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 34

Registration Number: NCT00959439

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Phase 1

Completed

Conditions: Hirsutism
Prostate Cancer

Interventions: Drug: Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA)
Drug: Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA)

First Posted Date: 2009-08-14

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00959335

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Nausea
Vomiting

Interventions: Drug: Ondansetron HCl 24 mg Tablets (Sandoz, Inc.)
Drug: Zofran (Ondansetron HCl) 24 mg Tablets (GlaxoSmithKline)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 26

Registration Number: NCT00947128

To Demonstrate the Effect of Food on the Bioavailability of Glipizide

Phase 1

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast.
Drug: 10 mg Glucotrol Tablet (Roerig), Administered Immediately After a Standard Breakfast.
Drug: 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered After an Overnight Fast.

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 18

Registration Number: NCT00947024

To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Rheumatoid Arthritis
Psoriatic Arthritis

Interventions: Drug: Leflunomide 20 mg Tablets (Geneva Pharmaceutical)
Drug: Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 52

Registration Number: NCT00946686

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy